- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Picker nabs $22 million contract
Picker International continues to enjoy success in securing federal defense contracts for medical imaging equipment. The company announced this month that it won a contract worth $22 million to supply CT scanners to the Department of Defense (DOD).
Picker International continues to enjoy success in securing federal defense contracts for medical imaging equipment. The company announced this month that it won a contract worth $22 million to supply CT scanners to the Department of Defense (DOD).
Under the terms of the contract, any DOD facility or otherfederal agency that leases a CT scanner in the next three yearswill lease a Picker scanner. Picker estimates that the contracthas a potential value of over $22 million in the first year alone.Financing for the leases will be provided by Picker FinancialGroup, a joint venture between Picker and LDI of Cleveland.
Defense contracts are a lucrative revenue stream for the Cleveland-basedvendor. Earlier this year Picker won a contract worth $6.2 millionto supply DOD with x-ray equipment (SCAN 1/19/94).
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
